Targeted T cell receptor gene editing provides predictable T cell product function for immunotherapy
Mueller TR, Jarosch S, Hammel M, Leube J, Grassmann S, Bernard B, Effenberger M, Andrae I, Chaudhry MZ, Kaeuferle T, Malo A, Cicin-Sain L, Steinberger P, Feuchtinger T, Protzer U, Schumann K, Neuenhahn M, Schober K, Busch DH (2021)
Publication Status: Published
Publication Type: Journal article, Original article
Publication year: 2021
Journal
Publisher: Cell Press
Book Volume: 2
Article Number: 100374
Journal Issue: 8
DOI: 10.1016/j.xcrm.2021.100374
Authors with CRIS profile
Involved external institutions
Helmholtz-Zentrum für Infektionsforschung (HZI)
Germany (DE)
Medizinische Universität Wien
Austria (AT)
Technische Universität München (TUM)
Germany (DE)
Deutsches Zentrum für Infektionsforschung (DZIF)
Germany (DE)
Germany (DE)
Medizinische Universität Wien
Austria (AT)
Technische Universität München (TUM)
Germany (DE)
Deutsches Zentrum für Infektionsforschung (DZIF)
Germany (DE)
How to cite
APA:
Mueller, T.R., Jarosch, S., Hammel, M., Leube, J., Grassmann, S., Bernard, B.,... Busch, D.H. (2021). Targeted T cell receptor gene editing provides predictable T cell product function for immunotherapy. Cell Reports Medicine, 2(8). https://doi.org/10.1016/j.xcrm.2021.100374
MLA:
Mueller, Thomas R., et al. "Targeted T cell receptor gene editing provides predictable T cell product function for immunotherapy." Cell Reports Medicine 2.8 (2021).
BibTeX: Download